Conformationally constrained peptide analogues of pTyr-Glu-Glu-Ile as inhibitors of the src SH2 domain binding

被引:55
作者
Nam, NH
Ye, GF
Sun, GQ
Parang, K [1 ]
机构
[1] Univ Rhode Isl, Dept Biomed Sci, Kingston, RI 02881 USA
[2] Univ Rhode Isl, Dept Cell & Mol Biol, Kingston, RI 02881 USA
关键词
D O I
10.1021/jm040008+
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of conformationally constrained peptides were designed and synthesized as the Src SH2 domain ligands based on a tetrapeptide sequence pTyr-Glu-Glu-Ile (pYEEI). In general, the constrained peptides such as compounds 6, 7, and 11 (IC50 = 1.1-1.5 muM) showed higher binding affinities to the Src SH2 domain relative to the corresponding linear peptides 8a, 9a, and 13a, respectively (IC50 > 100 muM), and pYEEI (IC50 = 6.5 muM), as evaluated by a fluorescence polarization assay. Molecular modeling studies revealed that in constrained peptides, the isoleucine side chain penetrates very deeply into the hydrophobic binding pocket (P + 3 site) of the Src SH2 domain. These constrained peptides can serve as novel templates for the design of small and nonpeptidic inhibitors of the Src SH2 domain.
引用
收藏
页码:3131 / 3141
页数:11
相关论文
共 36 条
[11]   Imidazole-based ligands of the Src SH2 protein [J].
Deprez, P ;
Mandine, E ;
Vermond, A ;
Lesuisse, D .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (09) :1287-1289
[12]   RECOGNITION OF A HIGH-AFFINITY PHOSPHOTYROSYL PEPTIDE BY THE SRC HOMOLOGY-2 DOMAIN OF P56(LCK) [J].
ECK, MJ ;
SHOELSON, SE ;
HARRISON, SC .
NATURE, 1993, 362 (6415) :87-91
[13]  
El Haddadi M, 2000, J PEPT SCI, V6, P560, DOI 10.1002/1099-1387(200011)6:11<560::AID-PSC275>3.3.CO
[14]  
2-9
[15]   Structural and conformational requirements for high-affinity binding to the SH2 domain of Grb2 [J].
Ettmayer, P ;
France, D ;
Gounarides, J ;
Jarosinski, M ;
Martin, MS ;
Rondeau, JM ;
Sabio, M ;
Topiol, S ;
Weidmann, B ;
Zurini, M ;
Bair, KW .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (06) :971-980
[16]   Chemical synthesis of natural product peptides: Coupling methods for the incorporation of noncoded amino acids into peptides [J].
Humphrey, JM ;
Chamberlin, AR .
CHEMICAL REVIEWS, 1997, 97 (06) :2243-2266
[17]   A novel phosphotyrosine mimetic 4′-carboxymethyloxy-3′-phosphonophenylalanine (Cpp):: Exploitation in the design of nonpeptide inhibitors of pp60Src SH2 domain [J].
Kawahata, N ;
Yang, MG ;
Luke, GP ;
Shakespeare, WC ;
Sundaramoorthi, R ;
Wang, YH ;
Johnson, D ;
Merry, T ;
Violette, S ;
Guan, W ;
Bartlett, C ;
Smith, J ;
Hatada, M ;
Lu, XD ;
Dalgarno, DC ;
Eyermann, CJ ;
Bohacek, RS ;
Sawyer, TK .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (17) :2319-2323
[18]   Lowering the entropic barrier for binding conformationally flexible inhibitors to enzymes [J].
Khan, AR ;
Parrish, JC ;
Fraser, ME ;
Smith, WW ;
Bartlett, PA ;
James, MNG .
BIOCHEMISTRY, 1998, 37 (48) :16839-16845
[19]   SAR and X-ray.: A new approach combining fragment-based screening and rational drug design:: Application to the discovery of nanomolar inhibitors of Src SH2 [J].
Lesuisse, D ;
Lange, G ;
Deprez, P ;
Bénard, D ;
Schoot, B ;
Delettre, G ;
Marquette, JP ;
Broto, P ;
Jean-Baptiste, V ;
Bichet, P ;
Sarubbi, E ;
Mandine, E .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (12) :2379-2387
[20]   Discovery of thioazepinone ligands for Src SH2: From non-specific to specific binding [J].
Lesuisse, D ;
Deprez, P ;
Albert, E ;
Duc, TT ;
Sortais, B ;
Gofflo, D ;
Jean-Baptiste, V ;
Marquette, JP ;
Schoot, B ;
Sarubbi, E ;
Lange, G ;
Broto, P ;
Mandine, E .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (16) :2127-2131